{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:53:41Z","timestamp":1793170421025,"version":"4.5.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","worldneurosurgery.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.wneu.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T00:30:18Z","timestamp":1500078618000},"page":"509-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury"],"prefix":"10.1016","volume":"106","author":[{"given":"Ahmed M.","family":"Alnemari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna M.","family":"Krafcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek R.","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2697-9336","authenticated-orcid":false,"given":"Daniel","family":"Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2017.07.009_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3233\/NRE-2007-22502","article-title":"The impact of traumatic brain injuries: a global perspective","volume":"22","author":"Hyder","year":"2007","journal-title":"NeuroRehabilitation"},{"key":"10.1016\/j.wneu.2017.07.009_bib2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fphar.2016.00342","article-title":"Inflammation following traumatic brain injury in humans: insights from data-driven and mechanistic models into survival and death","volume":"7","author":"Abboud","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.wneu.2017.07.009_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/2152-7806.170248","article-title":"Mannitol or hypertonic saline in the setting of traumatic brain injury: what have we learned?","volume":"6","author":"Boone","year":"2015","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.wneu.2017.07.009_bib4","series-title":"Intracranial Pressure: Monitoring and Management","author":"Mariano GSL","year":"2012"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2017.07.009_bib5","first-page":"S55","article-title":"Guidelines for the management of severe traumatic brain injury. VIII. Intracranial pressure thresholds","volume":"24","year":"2007","journal-title":"J\u00a0Neurotrauma"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2017.07.009_bib6","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1089\/neu.2007.9994","article-title":"Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy","volume":"24","author":"Bratton","year":"2007","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition","volume":"80","author":"Carney","year":"2016","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.07.009_bib8","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1016\/j.injury.2014.08.041","article-title":"Responsiveness to therapy for increased intracranial pressure in traumatic brain injury is associated with neurological outcome","volume":"45","author":"Colton","year":"2014","journal-title":"Injury"},{"key":"10.1016\/j.wneu.2017.07.009_bib9","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1089\/neu.2014.3376","article-title":"Post-traumatic multimodal brain monitoring: response to hypertonic saline","volume":"31","author":"Dias","year":"2014","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3171\/2013.4.JNS121541","article-title":"Effective treatment of refractory intracranial hypertension after traumatic brain injury with repeated boluses of 14.6% hypertonic saline","volume":"119","author":"Eskandari","year":"2013","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.009_bib11","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/CCM.0b013e31819c1933","article-title":"Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients","volume":"37","author":"Froelich","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1080\/01616412.1999.11741010","article-title":"Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates","volume":"21","author":"Horn","year":"1999","journal-title":"Neurol Res"},{"key":"10.1016\/j.wneu.2017.07.009_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11845-014-1080-9","article-title":"Single bolus 30% hypertonic saline for refractory intracranial hypertension","volume":"184","author":"Major","year":"2015","journal-title":"Irish J Med Sci"},{"key":"10.1016\/j.wneu.2017.07.009_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/neu.2000.17.41","article-title":"Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure","volume":"17","author":"Munar","year":"2000","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12028-011-9574-z","article-title":"Hypertonic saline reduces intracranial hypertension in the presence of high serum and cerebrospinal fluid osmolalities","volume":"17","author":"Paredes-Andrade","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib16","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1227\/01.NEU.0000359533.16214.04","article-title":"Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen","volume":"65","author":"Rockswold","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.07.009_bib17","doi-asserted-by":"crossref","first-page":"R260","DOI":"10.1186\/cc10522","article-title":"Continuous controlled-infusion of hypertonic saline solution in traumatic brain-injured patients: a 9-year retrospective study","volume":"15","author":"Roquilly","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib18","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-199806000-00038","article-title":"Treatment of refractory intracranial hypertension with 23.4% saline","volume":"26","author":"Suarez","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib19","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/cc11678","article-title":"The relationship between serum sodium and intracranial pressure when using hypertonic saline to target mild hypernatremia in patients with head trauma","volume":"16","author":"Wells","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib20","first-page":"126","article-title":"Hypertonic\/hyperoncotic saline reliably reduces ICP in severely head-injured patients with intracranial hypertension","volume":"70","author":"Hartl","year":"1997","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.wneu.2017.07.009_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-7-5","article-title":"Prehospital resuscitation with hypertonic saline-dextran modulates inflammatory, coagulation and endothelial activation marker profiles in severe traumatic brain injured patients","volume":"7","author":"Rhind","year":"2010","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.wneu.2017.07.009_bib22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12028-011-9512-0","article-title":"Randomized controlled trial comparing the effect of 8.4% sodium bicarbonate and 5% sodium chloride on raised intracranial pressure after traumatic brain injury","volume":"15","author":"Bourdeaux","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1227\/NEU.0b013e3182417bc2","article-title":"Effect of mannitol on cerebral blood volume in patients with head injury","volume":"70","author":"Diringer","year":"2012","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.07.009_bib24","first-page":"1091","article-title":"Effect of hyperventilation, mannitol, and ventriculostomy drainage on cerebral blood flow after head injury","volume":"39","author":"Fortune","year":"1995","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/3-211-32318-X_16","article-title":"Linear correlation between stable intracranial pressure decrease and regional cerebral oxygenation improvement following mannitol administration in severe acute head injury patients","volume":"95","author":"Gasco","year":"2005","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.wneu.2017.07.009_bib26","first-page":"40","article-title":"Mannitol decreases ICP but does not improve brain-tissue pO2 in severely head-injured patients with intracranial hypertension","volume":"70","author":"Hartl","year":"1997","journal-title":"Acta Neurochir Suppl"},{"key":"10.1016\/j.wneu.2017.07.009_bib27","first-page":"292","article-title":"Effects of mannitol bolus administration on intracranial pressure, cerebral extracellular metabolites, and tissue oxygenation in severely head-injured patients","volume":"62","author":"Sakowitz","year":"2007","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/neu.2007.0411","article-title":"Characterizing the dose-response relationship between mannitol and intracranial pressure in traumatic brain injury patients using a high-frequency physiological data collection system","volume":"25","author":"Sorani","year":"2008","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib29","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s00701-006-0792-7","article-title":"Comparison of moderate hyperventilation and mannitol for control of intracranial pressure control in patients with severe traumatic brain injury\u2014a study of cerebral blood flow and metabolism","volume":"148","author":"Soustiel","year":"2006","journal-title":"Acta Neurochir (Wien)"},{"issue":"5 suppl","key":"10.1016\/j.wneu.2017.07.009_bib30","first-page":"S32","article-title":"Multimodal monitoring in patients with head injury: evaluation of the effects of treatment on cerebral oxygenation","volume":"42","author":"Unterberg","year":"1997","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/CCM.0B013E3181643B41","article-title":"Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure","volume":"36","author":"Francony","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jocn.2015.08.035","article-title":"An equiosmolar study on early intracranial physiology and long-term outcome in severe traumatic brain injury comparing mannitol and hypertonic saline","volume":"27","author":"Jagannatha","year":"2016","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2017.07.009_bib33","first-page":"277","article-title":"The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study","volume":"67","author":"Kerwin","year":"2009","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3171\/2014.10.JNS132545","article-title":"Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury","volume":"122","author":"Mangat","year":"2015","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.009_bib35","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/jnnp.2008.156596","article-title":"Effect of mannitol and hypertonic saline on cerebral oxygenation in patients with severe traumatic brain injury and refractory intracranial hypertension","volume":"80","author":"Oddo","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.wneu.2017.07.009_bib36","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3171\/2010.5.JNS091685","article-title":"Comparison of mannitol and hypertonic saline in the treatment of severe brain injuries","volume":"114","author":"Sakellaridis","year":"2011","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.009_bib37","doi-asserted-by":"crossref","first-page":"526.e7","DOI":"10.1016\/j.jcrc.2011.10.008","article-title":"Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury","volume":"27","author":"Scalfani","year":"2012","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib38","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/neurosurgery\/57.4.727","article-title":"Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study","volume":"57","author":"Ware","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.wneu.2017.07.009_bib39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00134-013-2978-9","article-title":"Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: a randomized controlled trial","volume":"39","author":"Ichai","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib40","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00134-008-1283-5","article-title":"Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients","volume":"35","author":"Ichai","year":"2009","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib41","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s12028-011-9526-7","article-title":"Medical management of compromised brain oxygen in patients with severe traumatic brain injury","volume":"14","author":"Bohman","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib42","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3171\/jns.1996.85.5.0758","article-title":"Adverse effects of pentobarbital on cerebral venous oxygenation of comatose patients with acute traumatic brain swelling: relationship to outcome","volume":"85","author":"Cruz","year":"1996","journal-title":"J\u00a0Neurosurg"},{"issue":"8 suppl","key":"10.1016\/j.wneu.2017.07.009_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7205\/MILMED-D-12-00142","article-title":"Diagnosis and management of moderate and severe traumatic brain injury sustained in combat","volume":"177","author":"Marshall","year":"2012","journal-title":"Mil Med"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2017.07.009_bib44","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/0976-3147.116441","article-title":"Decrease in white blood cell counts after thiopentone barbiturate therapy for refractory intracranial hypertension: a common complication","volume":"4","author":"Ng","year":"2013","journal-title":"J\u00a0Neurosci Rural Pract"},{"key":"10.1016\/j.wneu.2017.07.009_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF01406868","article-title":"The effect of high dose barbiturate decompression after severe head injury. A controlled clinical trial","volume":"72","author":"Nordby","year":"1984","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.wneu.2017.07.009_bib46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00134-007-0948-9","article-title":"Refractory intracranial hypertension and \u201csecond-tier\u201d therapies in traumatic brain injury","volume":"34","author":"Stocchetti","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib47","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1097\/00003246-199907000-00028","article-title":"Thiopental attenuates energetic impairment but fails to normalize cerebrospinal fluid glutamate in brain-injured patients","volume":"27","author":"Stover","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib48","doi-asserted-by":"crossref","first-page":"R112","DOI":"10.1186\/cc6999","article-title":"Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial","volume":"12","author":"Perez-Barcena","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib49","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/0885066614555692","article-title":"Pharmacologic treatment reduces pressure times time dose and relative duration of intracranial hypertension","volume":"31","author":"Colton","year":"2016","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/TA.0000000000000270","article-title":"Intracranial pressure response after pharmacologic treatment of intracranial hypertension","volume":"77","author":"Colton","year":"2014","journal-title":"J\u00a0Trauma Acute Care Surg"},{"key":"10.1016\/j.wneu.2017.07.009_bib51","doi-asserted-by":"crossref","first-page":"R77","DOI":"10.1186\/cc12686","article-title":"Balanced versus chloride-rich solutions for fluid resuscitation in brain-injured patients: a randomised double-blind pilot study","volume":"17","author":"Roquilly","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib52","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1097\/00003246-200011000-00009","article-title":"Midazolam and 2% propofol in long-term sedation of traumatized, critically ill patients: efficacy and safety comparison","volume":"28","author":"Sandiumenge Camps","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib53","doi-asserted-by":"crossref","DOI":"10.1177\/0885066616689555","article-title":"Dexmedetomidine for refractory intracranial hypertension","author":"Schomer","year":"2017","journal-title":"J\u00a0Intensive Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib54","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/00000542-199510000-00011","article-title":"Effects of sufentanil on cerebral hemodynamics and intracranial pressure in patients with brain injury","volume":"83","author":"Werner","year":"1995","journal-title":"Anesthesiology"},{"key":"10.1016\/j.wneu.2017.07.009_bib55","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1399-6576.1997.tb04651.x","article-title":"Effects of cisatracurium on cerebral and cardiovascular hemodynamics in patients with severe brain injury","volume":"41","author":"Schramm","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.wneu.2017.07.009_bib56","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1471-4159.1983.tb09065.x","article-title":"Sodium transport in capillaries isolated from rat brain","volume":"41","author":"Betz","year":"1983","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2017.07.009_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4103\/1817-1745.66673","article-title":"Role of hypertonic saline and mannitol in the management of raised intracranial pressure in children: a randomized comparative study","volume":"5","author":"Upadhyay","year":"2010","journal-title":"J\u00a0Pediatr Neurosci"},{"issue":"5 suppl","key":"10.1016\/j.wneu.2017.07.009_bib58","first-page":"S27","article-title":"7.5% saline and 7.5% saline\/6% dextran for hypovolemic shock","volume":"70","author":"Bulger","year":"2011","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3171\/jns.1962.19.10.0897","article-title":"The use of mannitol for the reduction of intracranial pressure in intracranial surgery","volume":"19","author":"Shenkin","year":"1962","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.009_bib60","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3171\/jns.1985.63.1.0043","article-title":"Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury","volume":"63","author":"Mendelow","year":"1985","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.009_bib61","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1471-4159.1997.69010423.x","article-title":"Brain lactate is an obligatory aerobic energy substrate for functional recovery after hypoxia: further in\u00a0vitro validation","volume":"69","author":"Schurr","year":"1997","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.wneu.2017.07.009_bib62","first-page":"131","article-title":"Lactate, glucose and energy metabolism in the ischemic brain [review]","volume":"10","author":"Schurr","year":"2002","journal-title":"Int J Mol Med"},{"issue":"suppl 1","key":"10.1016\/j.wneu.2017.07.009_bib63","first-page":"S71","article-title":"Guidelines for the management of severe traumatic brain injury. XI. Anesthetics, analgesics, and sedatives","volume":"24","year":"2007","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.wneu.2017.07.009_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3171\/jns.1988.69.1.0015","article-title":"High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury","volume":"69","author":"Eisenberg","year":"1988","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2017.07.009_bib65","first-page":"150","article-title":"Neuroprotective effects of anesthetic agents","volume":"19","author":"Kawaguchi","year":"2005","journal-title":"J\u00a0Anesth"},{"key":"10.1016\/j.wneu.2017.07.009_bib66","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/cc7795","article-title":"Propofol: neuroprotection in an in\u00a0vitro model of traumatic brain injury","volume":"13","author":"Rossaint","year":"2009","journal-title":"Crit Care"},{"key":"10.1016\/j.wneu.2017.07.009_bib67","doi-asserted-by":"crossref","first-page":"637171","DOI":"10.1155\/2012\/637171","article-title":"Sedation in traumatic brain injury","volume":"2012","author":"Flower","year":"2012","journal-title":"Emerg Med Int"},{"key":"10.1016\/j.wneu.2017.07.009_bib68","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s00134-004-2417-z","article-title":"Dexmedetomidine infusion for more than 24 hours in critically ill patients: sedative and cardiovascular effects","volume":"30","author":"Shehabi","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib69","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00000542-199209000-00002","article-title":"Fentanyl and sufentanil increase intracranial pressure in head trauma patients","volume":"77","author":"Sperry","year":"1992","journal-title":"Anesthesiology"},{"key":"10.1016\/j.wneu.2017.07.009_bib70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00003246-199902000-00050","article-title":"Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics","volume":"27","author":"Albanese","year":"1999","journal-title":"Crit Care Med"},{"key":"10.1016\/j.wneu.2017.07.009_bib71","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00000542-200001000-00008","article-title":"Cerebral hemodynamic effects of morphine and fentanyl in patients with severe head injury: absence of correlation to cerebral autoregulation","volume":"92","author":"de Nadal","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.wneu.2017.07.009_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00000542-198209000-00019","article-title":"A\u00a0randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning","volume":"57","author":"White","year":"1982","journal-title":"Anesthesiology"},{"key":"10.1016\/j.wneu.2017.07.009_bib73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/bja\/57.4.375","article-title":"Comparison between high-dose sufentanil-oxygen and high-dose fentanyl-oxygen for neuroanaesthesia","volume":"57","author":"Shupak","year":"1985","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.wneu.2017.07.009_bib74","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00000542-199607000-00023","article-title":"Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats","volume":"85","author":"Wastila","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1016\/j.wneu.2017.07.009_bib75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/cc9052","article-title":"Bench-to-bedside review: chloride in critical illness","volume":"14","author":"Yunos","year":"2010","journal-title":"Crit Care"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017311087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875017311087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T12:56:46Z","timestamp":1602507406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875017311087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":75,"alternative-id":["S1878875017311087"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2017.07.009","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}